Reference: Krivic A, Majerovic M, Jelic I, Seiwerth S, Sikiric P
Long-term studies of semaglutide found that after 68 weeks of treatment, patients actually reported better physical functioning and energy levels than when they started
The powder form protects the delicate amino acid chains during transport and storage by removing water and preventing oxygen and moisture from entering
Functionally, semaglutide retains full agonist potency at the human GLP-1 receptor
What Studies Exist and Whats Missing We might have little info but a small number of recent studies that looked directly at breast milk are promising: Semaglutide milk study: One small study measured breast milk from eight breastfeeding women using injectable semaglutide and found no detectable drug levels
Restarting at a lower dose and re-titrating up over several weeks is the safer approach